Yu‐Wei Lin

526 total citations
33 papers, 384 citations indexed

About

Yu‐Wei Lin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yu‐Wei Lin has authored 33 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Yu‐Wei Lin's work include Advanced Radiotherapy Techniques (7 papers), Head and Neck Cancer Studies (7 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Yu‐Wei Lin is often cited by papers focused on Advanced Radiotherapy Techniques (7 papers), Head and Neck Cancer Studies (7 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Yu‐Wei Lin collaborates with scholars based in Taiwan, United States and United Kingdom. Yu‐Wei Lin's co-authors include Li‐Ching Lin, Ching‐Chieh Yang, Kuei‐Li Lin, Ming‐Hong Tai, Shih‐Chang Wang, Jenny Que, Ching‐Chih Lee, Steve P. Lee, Chia‐Hui Lin and Chung‐I Huang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Yu‐Wei Lin

32 papers receiving 376 citations

Peers

Yu‐Wei Lin
Min Kyu Kang South Korea
Eli Sapir United States
Takeaki Ishihara Japan
Jinhyun Choi South Korea
Yusuke Azami Japan
Stanley I. Gutiontov United States
Eyad Abu‐Isa United States
Jonathan Feddock United States
E. Rio France
K. Matsuura Japan
Min Kyu Kang South Korea
Yu‐Wei Lin
Citations per year, relative to Yu‐Wei Lin Yu‐Wei Lin (= 1×) peers Min Kyu Kang

Countries citing papers authored by Yu‐Wei Lin

Since Specialization
Citations

This map shows the geographic impact of Yu‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wei Lin more than expected).

Fields of papers citing papers by Yu‐Wei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wei Lin. The network helps show where Yu‐Wei Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Wei Lin. A scholar is included among the top collaborators of Yu‐Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Wei Lin. Yu‐Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Tsung‐Hui, Hsiao‐Mei Kuo, Mei‐Lang Kung, et al.. (2025). Hepatoma-Derived Growth Factor Promotes Liver Carcinogenesis by Inducing Phosphatase and Tensin Homolog Inactivation. Laboratory Investigation. 105(6). 104127–104127.
2.
Wang, Bing‐Yen, Yuan‐Yen Chang, Li‐Yen Shiu, et al.. (2023). An integrated analysis of dysregulated SCD1 in human cancers and functional verification of miR-181a-5p/SCD1 axis in esophageal squamous cell carcinoma. Computational and Structural Biotechnology Journal. 21. 4030–4043. 4 indexed citations
3.
Hu, Tsung‐Hui, Jian‐Ching Wu, Shih‐Tsung Huang, et al.. (2023). HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria. Journal of Biological Chemistry. 299(11). 105335–105335. 5 indexed citations
4.
Chu, Tian‐Huei, Yi‐Chen Chang, Chao‐Cheng Huang, et al.. (2022). Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma. Journal of Biological Chemistry. 298(10). 102442–102442. 7 indexed citations
5.
Huang, Shih‐Chung, Chen‐Lin Chang, Wen‐Chin Lee, et al.. (2022). DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes. 13(4). 629–629. 2 indexed citations
6.
Yang, Ching‐Chieh, et al.. (2021). The new SRS/FSRT technique HyperArc for benign brain lesions: a dosimetric analysis. Scientific Reports. 11(1). 21029–21029. 7 indexed citations
7.
8.
9.
10.
Wang, Shih‐Chang, Li‐Ching Lin, Yu‐Ting Kuo, & Yu‐Wei Lin. (2018). Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy. Frontiers in Oncology. 8. 546–546. 17 indexed citations
11.
Lee, Ching‐Chih, Yu‐Chieh Su, Shih‐Kai Hung, et al.. (2017). Recommendation for incorporation of a different lymph node scoring system in future AJCC N category for oral cancer. Scientific Reports. 7(1). 14117–14117. 26 indexed citations
12.
Que, Jenny, Hsing‐Tao Kuo, Li‐Ching Lin, et al.. (2016). Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma. BMC Cancer. 16(1). 451–451. 31 indexed citations
13.
Lin, Yu‐Wei, Chia‐Chun Chen, Li‐Ching Lin, & Steve P. Lee. (2015). The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma. PLoS ONE. 10(4). e0125283–e0125283. 9 indexed citations
14.
15.
Lin, Yu‐Wei, Li‐Ching Lin, & Kuei‐Li Lin. (2014). The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer. Frontiers in Oncology. 4. 278–278. 30 indexed citations
16.
Lin, Yu‐Wei, Kai‐Hsin Lin, & Li‐Ching Lin. (2014). The 4-Year Result of Stereotactic Body Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 90(1). S427–S427. 1 indexed citations
17.
Que, Jenny, Li‐Ching Lin, Kuei‐Li Lin, et al.. (2014). The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities. Radiation Oncology. 9(1). 120–120. 36 indexed citations
18.
Lin, Yu‐Wei, Jenny Que, Chien‐Feng Li, Kuei‐Li Lin, & Li‐Ching Lin. (2009). Primary Angiosarcoma of the Breast. 16(2). 99–108. 2 indexed citations
19.
Lin, Yu‐Wei, Li‐Ching Lin, Chien‐Feng Li, Jenny Que, & Kuei‐Li Lin. (2009). Lymphoepithelial Carcinoma of the Sublingual Gland Associated with EBV Infection: A Case Report. 16(1). 69–78. 1 indexed citations
20.
Phillis, John W. & Yu‐Wei Lin. (1991). Oxypurinol Reduces Ischemic Brain Injury in the Gerbil and Rat. Advances in experimental medicine and biology. 309A. 343–346. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Kyu Kang Breakdown of academic impact, for papers by Eli Sapir Breakdown of academic impact, for papers by Takeaki Ishihara Breakdown of academic impact, for papers by Jinhyun Choi Breakdown of academic impact, for papers by Yusuke Azami Breakdown of academic impact, for papers by Stanley I. Gutiontov Breakdown of academic impact, for papers by Eyad Abu‐Isa Breakdown of academic impact, for papers by Jonathan Feddock Breakdown of academic impact, for papers by E. Rio Breakdown of academic impact, for papers by K. Matsuura
Rankless by CCL
2026